GrantQuick

health · HHS-NIH11

Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Radiological/Nuclear or Chemical Threats (U01 Clinical Trial Not Allowed)

National Institutes of Health · RFA-AI-27-014

732 days left

Deadline

October 9, 2028

GRANTQUICK SUMMARYPlain-English Overview

Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Chemical or Radiation/Nuclear (CRN) Threats. National Institutes of Health. The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance the NIH mission by supporting research on concepts and technologies to address civilian radiation or chemical threats. Research is administered by NIAID on behalf of NIH via the Radiation and Nuclear (RNCP), and... Funding amounts not specified.

Who Should Apply

Other eligible entities, Public And Indian Housing Authorities, Other Native American Tribal Organizations, Nonprofits (non-501c3), For-profit organizations (+10 more)

Who Should NOT Apply

Organizations not matching the eligible applicant types listed above

Key Requirements (Plain English)

  • •Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U

💡 GrantQuick Tip

Focus your proposal on clear outcomes, alignment with agency priorities, and demonstrate organizational capacity.

Competitiveness: Moderate to high — federal grants are always competitive

What This Grant Funds

The purpose of this notice of funding opportunity (NOFO) is to support research that advances understanding of the natural history of radiation or chemical exposures; develops relevant injury models; identifies and validates diagnostic tools, biomarkers, or triage technologies; and supports the development of effective medical countermeasures (MCMs) to mitigate or treat acute and/or delayed injuries resulting from radiological/nuclear or chemical public health emergencies.

Attachments

Who Can Apply

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.NIH will no longer issue awards (i.e., new, renewal, or non-competing continuation) to domestic or foreign entities that involve foreign subawards/subcontracts. All NIH-funded research involving foreign subawards/subcontracts must be submitted in response to a NOFO that is specifically designated for funded international collaborations. See NIH Grants Policy Statement 16.8 Collaborative International Research Awards.Applications involving foreign subawards/subcontracts submitted in response to this NOFO will be deemed noncompliant and will not be considered for funding. This policy applies to all monetary international collaborations resulting in foreign subawards/subcontracts, however, it does not preclude unfunded international collaborations or foreign components, funding for foreign consultants, or procurement of unique equipment or supplies from foreign vendors.

Eligible Applicant Types

Independent School DistrictsFederally Recognized Tribal GovernmentsSmall BusinessesSpecial District GovernmentsOther Tribal OrganizationsCity/Township Governments501(c)(3) NonprofitsPublic Colleges & UniversitiesPublic And Indian Housing AuthoritiesOther (see NOFO for details)Private Colleges & UniversitiesFor-Profit OrganizationsCounty GovernmentsState GovernmentsNonprofits without 501(c)(3)

Funding Details

Cost Sharing Required?
No
Funding Instrument
cooperative_agreement

Key Dates

Posted: September 1, 2026
Application Deadline: October 9, 2028 (732 days remaining)

Agency Contact

National Institute of Allergy and Infectious Diseases (NIAID) RADCHEM_U01@mail.nih.gov

RADCHEM_U01@mail.nih.gov

Ready to apply?

View the full NOFO and submit your application on Grants.gov